AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Propanc Biopharma, Inc. Director's Dealing 2012

Aug 22, 2012

34906_dirs_2012-08-22_83515b9f-3c44-4cbc-a5c9-534240ea8cfb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Propanc Health Group Corp (PPCH)
CIK: 0001517681
Period of Report: 2012-07-16

Reporting Person: Kenyon Julian Norman (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Shares in Propanc Health Group Corp.	10812064	Direct

Footnotes

F1: This Form 3 Amendment is being filed to correct a clerical error in the initial Form 3 report that mistakenly misrepresented the total amount beneficially owned by the Dr. Julian Kenyon.